Waters Corporation logo
Waters Corporation (WAT)
Compare

Waters Corporation (WAT) Return on Equity (ROE): 2.94%

Is Waters Corporation’s return on equity (ROE) high or low?

Waters Corporation's return on equity (ROE) of 2.94% is 97% below its 5-year average of 111.55%, near the low end of its 5-year range (2.94%–224.68%).

As of Friday, June 12, 2026. 90.20% below its 12-month average of 29.98%.

WAT Return on Equity (ROE) Chart

WAT Return on Equity (ROE)
25.09%-28.07% 1Y
Zoom

WAT Average Return on Equity (ROE) Chart

WAT Current vs Average Return on Equity (ROE) Chart

WAT Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

2.94%

RETURN ON EQUITY (ROE) AVG TTM

29.98%

RETURN ON EQUITY (ROE) AVG 3Y

64.02%

RETURN ON EQUITY (ROE) AVG 5Y

111.55%

RETURN ON EQUITY (ROE) AVG 10Y

43.61%

RETURN ON EQUITY (ROE) AVG 15Y

39.40%

RETURN ON EQUITY (ROE) AVG 20Y

42.65%

CURRENT VS TTM AVG

-90.20%

CURRENT VS 3Y AVG

-95.41%

CURRENT VS 5Y AVG

-97.36%

CURRENT VS 10Y AVG

-93.26%

CURRENT VS 15Y AVG

-92.54%

CURRENT VS 20Y AVG

-93.11%

WAT Competitors' Return on Equity (ROE)

NAMEMARKET CAPRETURN ON EQUITY (ROE)TTM3Y5Y
Waters Corporation (WAT)$23.45B2.94%29.98%64.02%111.55%
United Therapeutics Corporation (UTHR)$23.15B21.82%18.68%17.25%16.03%
Mettler-Toledo International Inc. (MTD)$23.06B-3677.41%-2178.82%-341.14%-117.12%
BioNTech SE (BNTX)$22.52B-6.79%-4.55%10.63%21.70%
Veeva Systems Inc. (VEEV)$26.24B12.89%12.42%12.32%13.45%
Moderna, Inc. (MRNA)$19.70B-43.12%-32.64%-13.90%0.25%
DexCom, Inc. (DXCM)$29.04B31.47%28.93%25.01%22.95%
Biogen Inc. (BIIB)$29.52B7.36%8.42%11.86%16.52%
Hologic, Inc. (HOLX)$16.97B10.37%13.30%15.60%24.66%
IQVIA Holdings Inc. (IQV)$30.22B22.26%21.77%21.17%17.55%

Return Analysis

ROE

2.9%

ROA

1.8%

Waters Corporation Return on Equity (ROE) Formula & Definition

ROE = Net Income / Total Shareholders' Equity

Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Waters Corporation Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Waters Corporation (WAT)?
The return on equity (ROE) for WAT stock is 2.94%.
Is Waters Corporation's return on equity (ROE) high or low?
Waters Corporation's return on equity (ROE) of 2.94% is 97% below its 5-year average of 111.55%, near the low end of its 5-year range (2.94%–224.68%).
What is the TTM average return on equity (ROE) for Waters Corporation (WAT)?
The TTM average return on equity (ROE) for WAT stock is 29.98%.
What is the 3Y average return on equity (ROE) for Waters Corporation (WAT)?
The 3Y average return on equity (ROE) for WAT stock is 64.02%.
What is the 5Y average return on equity (ROE) for Waters Corporation (WAT)?
The 5Y average return on equity (ROE) for WAT stock is 111.55%.
What is the 10Y average return on equity (ROE) for Waters Corporation (WAT)?
The 10Y average return on equity (ROE) for WAT stock is 43.61%.
What is the 15Y average return on equity (ROE) for Waters Corporation (WAT)?
The 15Y average return on equity (ROE) for WAT stock is 39.40%.
What is the 20Y average return on equity (ROE) for Waters Corporation (WAT)?
The 20Y average return on equity (ROE) for WAT stock is 42.65%.

Waters Corporation Return on Equity (ROE) History

DATERETURN ON EQUITY (ROE)
2025-12-3125.09%
2024-12-3134.88%
2023-12-3155.83%
2022-12-31140.29%
2021-12-31188.50%
2020-12-31224.68%
2019-12-31-273.81%
2018-12-3137.89%
2017-12-310.91%
2016-12-3122.65%
2015-12-3122.78%
2014-12-3122.78%
2013-12-3125.52%
2012-12-3131.45%
2011-12-3135.30%
2010-12-3135.72%
2009-12-3138.08%
2008-12-3148.79%
2007-12-3145.74%
2006-12-3161.32%
2005-12-3171.21%
2004-12-3133.01%
2003-12-3128.94%
2002-12-3122.20%
2001-12-3119.69%
2000-12-3132.17%
1999-12-3141.85%
1998-12-3146.73%
1997-12-31-11.79%
1996-12-31-3.69%

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Milford, MA
7,600 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Udit Batra